Lung Tumors

In cancer immunotherapy, one PD-L1 test to rule them all?

Clinical trials have proven the power of immunotherapies targeting PD-L1 or PD-1 in a range of cancers. However, these same trials show that only some patients benefit - tumors must depend on PD-L1 to be affected when medicines ...

Dec 01, 2016
popularity3 comments 0

Researchers uncover protein-based 'cancer signature'

A research team at the University of Basel's Biozentrum has investigated the expression of ribosomal proteins in a wide range of human tissues including tumors and discovered a cancer type specific signature. As the researchers ...

Dec 05, 2016
popularity0 comments 0

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News